Lucid Diagnostics Inc. Common Stock
$0.79
$0.01 (+0.68%)
$0.77Day Range$0.80
Key Statistics
Market Cap
$150.03M
Shares Outstanding
190.9M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Oct 14, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$0.80
Day High
$0.80
Day Low
$0.77
Volume
2.40M
VWAP
$0.78
Prev Close
$0.78
Transactions
--
Acc. Volume
--
About Lucid Diagnostics Inc. Common Stock
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 384182 employees360 MADISON AVENUE, NEW YORK, NY, 10017212 949 4319IPO Oct 14, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001799011
- Composite FIGI
- BBG012NYMLC0
- Share Class FIGI
- BBG012NYMM65
- Ticker Root
- LUCD
- SIC Code
- 3841
About Lucid Diagnostics Inc. Common Stock (LUCD) Stock
Lucid Diagnostics Inc. Common Stock (LUCD) closed the 2026-09-18 session at $0.79, up 0.68% versus the previous close (+0.01). The stock opened at $0.80 and traded between $0.77 and $0.80 during that session. Session trading volume was 2.4M shares. The volume-weighted average price (VWAP) is $0.78.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Lucid Diagnostics Inc. Common Stock has a market capitalization of $150.0 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. LUCD is listed on the XNAS exchange. The company employs approximately 82 people. Lucid Diagnostics Inc. Common Stock is headquartered in NEW YORK, NY. The recorded listing date is 2021-10-14.
On this page you can find market LUCD stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.